Trafficking of Acetyl-C16-Ceramide-NBD with Long-Term Stability and No Cytotoxicity into the Golgi Complex

Traffic

Volumn 16, Issue 5, 2015, Pages 476-492

  Makiyama, Tomohiko ^a   Nakamura, Hiroyuki ^a   Nagasaka, Nobuo ^a   Yamashita, Hisahiro ^a   Honda, Takuya ^a   Yamaguchi, Naoto ^a   Nishida, Atsushi ^a   Murayama, Toshihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Acetyl C16 ceramide NBD; CERT; CHO cells; Cytotoxicity; Golgi complex

Indexed keywords

4 NITROBENZO 2 OXA 1,3 DIAZOLE; ACETIC ACID DERIVATIVE; CARRIER PROTEIN; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; IMIDAZOLE DERIVATIVE; SPHINGOMYELIN; UNCLASSIFIED DRUG; 4 CHLORO 7 NITROBENZOFURAZAN; ACETYL-C16-CERAMIDE-NBD; ARACHIDONIC ACID; FLUORESCENT DYE;

ANIMAL CELL; ARTICLE; CELL LABELING; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; GOLGI COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TRANSPORT; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE TECHNIQUE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CHO CELL LINE; CRICETULUS; DRUG EFFECTS; HUMAN; METABOLISM; MITOSIS; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; ULTRASTRUCTURE;

4-CHLORO-7-NITROBENZOFURAZAN; ANIMALS; ARACHIDONIC ACID; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; CERAMIDES; CHO CELLS; CRICETULUS; FLUORESCENT DYES; GOLGI APPARATUS; HUMANS; MITOSIS; MOLECULAR STRUCTURE;

EID: 84929995745     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12265     Document Type: Article

References (61)

1. Hakomori S. Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta 2008;1780:325-346.
2. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008;9:139-150.
3. Lipsky NG, Pagano RE. Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a fluorescent ceramide analogue. Proc Natl Acad Sci U S A 1983;80:2608-2612.
4. Lipsky NG, Pagano RE. A vital stain for the Golgi apparatus. Science 1985;228:745-747.
5. Pagano RE, Martin OC, Kang HC, Haugland RP. A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor. J Cell Biol 1991;113:1267-1279.
6. Di Biase A, Argiolas L, Confaloni A, Salvati S. In vivo metabolism of fluorescent ceramide in central nervous system myelin of adult rats. Neurochem Res 1991;16:551-554.
7. Jin M, Snider MD. Role of microtubules in transferrin receptor from the cell surface to endosomes and the Golgi complex. J Biol Chem 1993;268:18390-18397.
8. Seksek O, Biwersi J, Verkman AS. Evidence against defective trans-Golgi acidification in cystic fibrobrosis. J Biol Chem 1996;271:15542-15548.
9. Pagano RE, Puri V, Dominguez M, Marks DL. Membrane traffic in sphingolipid storage diseases. Traffic 2000;1:807-815.
10. Martin OC, Comly ME, Blanchette-Mackie EJ, Pentchev PG, Pagano RE. Cholesterol deprivation affects the fluorescence properties of a ceramide analog at the Golgi apparatus of living cells. Proc Natl Acad Sci U S A 1993;90:2661-2665.
11. Graf C, Klumpp M, Habig M, Rovina P, Billich A, Baumruker T, Oberhauser B, Bornancin F. Targeting ceramide metabolism with a potent and specific ceramide kinase inhibitor. Mol Pharmacol 2008;74:925-932.
12. Tada E, Toyomura K, Nakamura H, Sasaki H, Saito T, Kaneko M, Okuma Y, Murayama T. Activation of ceramidase and ceramide kinase by vanadate via a tyrosine kinase-mediated pathway. J Pharmacol Sci 2010;114:420-432.
13. Sasaki H, Toyomura K, Matsuzaki W, Okamoto A, Yamaguchi N, Nakamura H, Murayama T. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway. Arch Biochem Biophys 2014;550-551:12-19.
14. Puri V, Watanabe R, Singh RD, Dominguez M, Brown JC, Wheatley CL, Marks DL, Pagano RE. Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J Cell Biol 2001;154:535-547.
15. Singh RD, Puri V, Valiyaveettil JT, Marks DL, Bittman R, Pagano RE. Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol Biol Cell 2003;14:3254-3265.
16. Sharma DK, Choudhury A, Singh RD, Wheatley CL, Marks DL, Pagano RE. Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling. J Biol Chem 2003;278:7564-7572.
17. Nusshold C, Uellen A, Bernhart E, Hammer A, Damm S, Wintersperger A, Reicher H, Hermetter A, Malle E, Sattler W. Endocytosis and intracellular processing of BODIPY-sphingomyelin by murine CATH.a neurons. Biochim Biophys Acta 2013;1831:1665-1678.
18. 2α and inducer of cell toxicity. Biochem Pharmacol 2010;80:1396-1406.
19. 2. Eur J Pharmacol 2012;697:144-151.
20. Nakamura H, Murayama T. The role of sphingolipids in arachidonic acid metabolism. J Pharmacol Sci 2014;124:307-312.
21. Fukasawa M, Nishijima M, Hanada K. Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J Cell Biol 1999;144:673-685.
22. Pütz U, Schwarzmann G. Golgi staining by two fluorescent ceramide analogues in cultured fibroblasts requires metabolism. Eur J Cell Biol 1995;68:113-121.
23. Wolf DE, Winiski AP, Ting AE, Bocian KM, Pagano RE. Determination of the transbilayer distribution of fluorescent lipid analogues by nonradioactive fluorescence resonance energy transfer. Biochemistry 1992;31:2865-2873.
24. Wang QJ, Bhattacharyya D, Garfield S, Nacro K, Marquez VE, Blumberg PM. Differential localization of protein kinase C δ by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J Biol Chem 1999;274:37233-37239.
25. Gangalum RK, Schibler MJ, Bhat SP. Small heat shock protein αB-crystallin is part of cell cycle-dependent Golgi reorganization. J Biol Chem 2004;279:43374-43377.
26. Düwel M, Ungewickell EJ. Clathrin-dependent association of CVAK104 with endosomes and the trans-Golgi network. Mol Biol Cell 2006;17:4513-4525.
27. Meisslitzer-Ruppitsch C, Röhrl C, Ranftler C, Neumüller J, Vetterlein M, Ellinger A, Pavelka M. The ceramide-enriched trans-Golgi compartments reorganize together with other parts of the Golgi apparatus in response to ATP-depletion. Histochem Cell Biol 2011;135:159-171.
28. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. Molecular machinery for non-vesicular trafficking of ceramide. Nature 2003;426:803-809.
29. Yasuda S, Kitagawa H, Ueno M, Ishitani H, Fukasawa M, Nishijima M, Kobayashi S, Hanada K. A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis. J Biol Chem 2001;276:43994-44002.
30. Ďuriš A, Wiesenganger T, Moravčíková D, Baran P, Kožíšek J, Daïch A, Berkeš D. Expedient and practical synthesis of CERT-dependent ceramide trafficking inhibitor HPA-12 and its analogues. Org Lett 2011;13:1642-1645.
31. Ueno M, Huang YY, Yamano A, Kobayashi S. Revised stereochemistry of ceramide-trafficking inhibitor HPA-12 by X-ray crystallography analysis. Org Lett 2013;15:2869-2871.
32. Delgado A, Casas J, Llebaria A, Abad JL, Fabrias G. Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta 2006;1758:1957-1977.
33. Hu W, Xu R, Zhang G, Jin J, Szulc ZM, Bielawski J, Hannun YA, Obeid LM, Mao C. Golgi fragmentation is associated with ceramide-induced cellular effects. Mol Biol Cell 2005;16:1555-1567.
34. 2+ signaling. Cell Signal 2009;21:440-447.
35. Le Roy C, Wrana JL. Clathrin- and non-clathrin-mediated endocytotic regulation of cell signalling. Nat Rev Mol Cell Biol 2005;6:112-126.
36. Kirkham M, Parton RG. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid rafts carriers. Biochim Biophys Acta 2005;1745:273-286.
37. Liu X, Yuan Z, Chung M. MUC1 intra-cellular trafficking is clathrin, dynamin, and rab5 dependent. Biochem Biophys Res Commun 2008;376:688-693.
38. Kang YS, Zhao X, Lovaas J, Eisenberg E, Greene LE. Clathrin-independent internalization of normal cellular prion protein in neuroblastoma cells is associated with the Arf6 pathway. J Cell Sci 2009;122:4062-4069.
39. 1 angiotensin receptor. J Cell Biol 2002;157:1211-1222.
40. Martys JL, Wjasow C, Gangi DM, Kielian MC, McGraw TE, Backer JM. Wortmannin-sensitive trafficking pathways in Chinese hamster ovary cells: differential effects of endocytosis and lysosomal sorting. J Biol Chem 1996;271:10953-10962.
41. Altan-Bonnet N, Phair RD, Polishchuk RS, Weigert R, Lippincott-Schwartz J. A role for Arf1 in mitotic Golgi disassembly, chromosome segregation, and cytokinesis. Proc Natl Acad Sci U S A 2003;100:13314-13319.
42. Gaietta GM, Giepmans BN, Deerinck TJ, Smith WB, Ngan L, Llopis J, Adams SR, Tsien RY, Ellisman MH. Golgi twins in late mitosis revealed by genetically encoded tags for live cell imaging and correlated electron microscopy. Proc Natl Acad Sci U S A 2006;103:17777-17782.
43. Sundaramoorthy S, Goh JB, Rafee S, Murata-Hori M. Mitotic Golgi vesiculation involves mechanisms independent of Ser25 phosphorylation of GM130. Cell Cycle 2010;9:3100-3105.
44. Kolter T. A view on sphingolipids and disease. Chem Phys Lipids 2011;164:590-606.
45. Zigdon H, Meshcheriakova A, Futerman AH. From sheep to mice to cells: tools for the study of the sphingolipidoses. Biochim Biophys Acta 1841;2014:1189-1199.
46. 2 research: from cells to animals to humans. Prog Lipid Res 2011;50:152-192.
47. Thayer DA, Jan YN, Jan LY. Increased neuronal activity fragments the Golgi complex. Proc Natl Acad Sci U S A 2013;110:1482-1487.
48. Bexiga MG, Simpson JC. Human diseases associated with form and function of the Golgi complex. Int J Mol Sci 2013;14:18670-18681.
49. Hanada K, Voelker D. Interorganelle trafficking of lipids: preface for the thematic review series. Traffic 2014;15:889-894.
50. Boath A, Graf C, Lidome E, Ullrich T, Nussbaumer P, Bornancin F. Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin. J Biol Chem 2008;283:8517-8526.
51. Tóth B, Balla A, Ma H, Knight ZA, Shokat KM, Balla T. Phosphatidylinositol 4-kinase IIIβ regulates the transport of ceramide between the endoplasmic reticulum and Golgi. J Biol Chem 2006;281:36369-36377.
52. Kudo N, Kumagai K, Tomishige N, Yamaji T, Wakatsuki S, Nishijima M, Hanada K, Kato R. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A 2008;105:488-493.
53. Kumagai K, Yasuda S, Okemoto K, Nishijima M, Kobayashi S, Hanada K. CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem 2005;280:6488-6495.
54. Downing GJ, Kim S, Nakanishi S, Catt KJ, Balla T. Characterization of a soluble adrenal phosphatidylinositol 4-kinase reveals wortmannin sensitivity of type III phosphatidylinositol kinases. Biochemistry 1996;35:3587-3594.
55. Tafesse FG, Huitema K, Hermansson M, van der Poel S, van der Dikkenberg J, Uphoff A, Somerharju P, Holthuis JC. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells. J Biol Chem 2007;282:17537-17547.
56. Lamour NF, Stahelin RV, Wijesinghe DS, Maceyka M, Wang E, Allegood JC, Marrill AH Jr, Cho W, Chalfant CE. Ceramide kinase uses ceramide provided ceramide transport protein: localization to organelles of eicosanoid synthesis. J Lipid Res 2007;48:1293-1304.
57. Darroch PI, Dagan A, Granot T, He X, Gatt S, Schunchman EH. A lipid analogue that inhibits sphingomyelin hydrolysis and synthesis, increases ceramide, and leads to cell death. J Lipid Res 2005;46:2315-2324.
58. Keithley RB, Rosenthal AS, Essaka DC, Tanaka H, Yoshimura Y, Palcic MM, Hindsgaul O, Dovichi NJ. Capillary electrophoresis with three-color fluorescence detection for the analysis of glycosphingolipid metabolism. Analyst 2013;138:164-170.
59. Nakamura H, Wakita S, Suganami A, Tamura Y, Hanada K, Murayama T. Modulation of the activity of cytosolic phospholipase A2α (cPLA2α) by cellular sphingolipids and inhibition of cPLA2α by sphingomyelin. J Lipid Res 2010;51:720-728.
60. 2α. J Biol Chem 2013;288:23264-23272.
61. Nakayama Y, Matsui Y, Takeda Y, Okamoto M, Abe K, Fukumoto Y, Yamaguchi N. c-Src but not Fyn promotes proper spindle orientation in early prometaphase. J Biol Chem 2012;287:24905-24915.